[1]SMYTH EC,NILSSON M,GRABSCH HI,et al.Gastric cancer[J].Lancet,2020,396(10251):635-648.
[2]National Health Commission of the People's Republic of China.Chinese guidelines for diagnosis and treatment of gastric cancer 2018 (English version)[J].Chin J Cancer Res,2019,31(5):707-737.
[3]SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[4]CUPP MA,CARIOLOU M,TZOULAKI I,et al.Neutrophil to lymphocyte ratio and cancer prognosis:an umbrella review of systematic reviews and meta-analyses of observational studies[J].BMC Med,2020,18(1):360.
[5]CARRERA PM,KANTARJIAN HM,BLINDER VS.The financial burden and distress of patients with cancer:Understanding and stepping-up action on the financial toxicity of cancer treatment[J].CA Cancer J Clin,2018,68(2):153-165.
[6]MILLER KD,NOGUEIRA L,MARIOTTO AB,et al.Cancer treatment and survivorship statistics,2019[J].CA Cancer J Clin,2019,69(5):363-385.
[7]LIN JX,LIN JP,XIE JW,et al.Prognostic importance of the preoperative modified systemic inflammation score for patients with gastric cancer[J].Gastric Cancer,2019,22(2):403-412.
[8]FENG F,TIAN Y,XU G,et al.Diagnostic and prognostic value of CEA,CA19-9,AFP and CA125 for early gastric cancer[J].BMC Cancer,2022,17(1):737.
[9]SAHIN AB,CUBUKCU E,OCAK B,et al.Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy[J].Sci Rep,2021,11(1):14662.
[10]SUAREZ-CARMONA M,LESAGE J,CATALDO D,et al.EMT and inflammation:inseparable actors of cancer progression[J].Mol Oncol,2022,11(7):805-823.
[11]HOU J,KARIN M,SUN B.Targeting cancer-promoting inflammation-have anti-inflammatory therapies come of age[J].Nat Rev Clin Oncol,2021,18(5):261-279.
[12] LIU M,KALBASI A,BEATTY GL.Functio laesa:cancer inflammation and therapeutic resistance[J].J Oncol Pract,2017,13(3):173-180.
[13]OLINGY CE,DINH HQ,HEDRICK CC.Monocyte heterogeneity and functions in cancer[J].J Leukoc Biol,2019,106(2):309-322.
[14]WALRAVEN M,SABRKHANY S,KNOL JC,et al.Effects of cancer presence and therapy on the platelet proteome[J].Int J Mol Sci,2021,22(15):8236.
[15] CAMPELLO E,ILICH A,SIMIONI P,et al.The relationship between pancreatic cancer and hypercoagulability:a comprehensive review on epidemiological and biological issues[J].Br J Cancer,2019,121(5):359-371.
[16] WANG G,ZHANG HH,JIAO HB.Clinical significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio on the prognosis of patients for gastric cancer[J].J Mod Oncol,2017,25(24):4014-4017.
[17] JING R,CUI M,JU S,et al.The changes and clinical significance of preoperative and postoperative serum CEA and CA19-9 in gastric cancer[J].Clin Lab,2020,66(4):652-774.
[18]COFFELT SB,WELLENSTEIN MD,DE VISSER KE.Neutrophils in cancer:neutral no more[J].Nat Rev Cancer,2022,16(7):431-446.
[19]ANTONIO N,BONNELYKKE-BEHRNDTZ ML,WARD LC,et al.The wound inflammatory response exacerbates growth of pre-neoplastic cells and progression to cancer[J].EMBO J,2015,34(17):2219-2236.
[20]WEN S,CHEN N,HU Y,et al.Elevated peripheral absolute monocyte count related to clinicopathological features and poor prognosis in solid tumors:Systematic review,meta-analysis,and meta-regression[J].Cancer Med,2021,10(5):1690-1714.